Dianox is a founder-led pharmatech startup with a computational drug platform for targeting undruggable proteins. Big opportunity as 85% of proteins are undruggable with small molecules and unreachable by antibodies. Our platform consists of the world's largest aptamer database and proprietary Deep Learning models that enable us to generate novel nucleic acids for efficient delivery to previously undruggable proteins. We can accelerate drug discovery in oncology, dermatology and ophthalmology. We believe good health is the most important aspect of life. Our company is dedicated to building better therapeutics and diagnostics to help people in their health journey. We are always on the lookout for passionate partners in the health space. If you are excited about the potential of our work, please reach out via hello@dianox.com.